GP is an allosteric enzyme that plays a key role in glycogen catabolism to catalyze the phosphorylation reaction. GP exists in two different forms that are converted to each other, such as phosphorylated versus non-phosphorylated forms, and high substrate affinity versus low substrate affinity. Therefore, the development of GP inhibitors is considered to be an effective target for the treatment of abnormalities in glycogen metabolism. Combining click chemistry, CD BioGlyco provides professional GlycoCLICK™-based Drug Development services. We have extensive experience in developing GlycoCLICK™-based Enzyme Inhibitors and Carbohydrate Click-based Lectin Ligands. We provide GP inhibitor design, synthesis, and enzyme inhibition assay services for our clients.
Our researchers use click chemistry to synthesize many different GP inhibitors such as sugar-nucleoside and oleanolic acid-nucleoside conjugates, triazole derivatives, and oleanolic acid dimers.
For the synthesized derivatives, we evaluate enzyme inhibition assays against rabbit muscle glycogen phosphorylase a (RMGPa) and glycogen phosphorylase b. Our researchers measure and compare the inhibitory abilities of the derivatives.
Technology: Click chemistry, Copper(I)-catalyzed Huisgen cycloaddition reaction, Enzyme inhibition assay
Journal: Synthesis
Published: 2010
Results: In this study, researchers used click chemistry to synthesize novel nucleoside conjugates with uridine and N-acetylglucosamine or oleanolic acid derivatives. Uridine was converted to the azide derivative by activation of methanesulfonic acid and nucleophilic substitution with sodium azide. The desired compounds were then obtained by copper(I)-catalyzed Huisgen cycloaddition reaction, and finally, the conjugates were synthesized by cycloaddition reaction. Furthermore, enzyme inhibition assay of the synthesized conjugates revealed that these new molecules are potential glycogen phosphorylase inhibitors.
Fig.1 Structure of sugar-nucleoside conjugates. (Cheng, et al., 2010)
Combining click chemistry, CD BioGlyco provides professional GlycoCLICK™-based drug development services including GlycoCLICK™-based enzyme inhibitor and carbohydrate click-based lectin ligand development services. Our serious attitude and high-quality service have been recognized by our customers all over the world. Please feel free to
.References